News J&J trumpets new data from Tremfya as psoriasis market brace... Humira biosimilars set to launch in EU next month
News J&J's Tremfya gets funding in Germany and UK Johnson & Johnson’s psoriasis drug Tremfya has been given the green light for funding by cost-effectiveness bodies in the UK and Germany.
News FDA approves UCB’s Cimzia in plaque psoriasis The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis
News Escalier raises $19m to fund novel psoriasis pill Escalier Biosciences, a privately-held biopharma company based in The Netherlands, has raised $19 million to help advance its pipeline.
News Novartis trumpets long-term data for Cosentyx in psoriasis Novartis is hoping that new real world data will help its psoriasis drug Cosentyx stay ahead of rivals.
News AbbVie to file long-acting psoriasis contender AbbVie hopes risankizumab will rebuild sales after Humira patent expires
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.